Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Tampilan
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan